Your browser doesn't support javascript.
loading
Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease.
Yau, Kevin; Kurtesi, Alexandra; Qi, Freda; Delgado-Brand, Melanie; Tursun, Tulunay R; Hu, Queenie; Dhruve, Miten; Kandel, Christopher; Enilama, Omosomi; Levin, Adeera; Jiang, Yidi; Hardy, W Rod; Yuen, Darren A; Perl, Jeffrey; Chan, Christopher T; Leis, Jerome A; Oliver, Matthew J; Colwill, Karen; Gingras, Anne-Claude; Hladunewich, Michelle A.
Afiliación
  • Yau K; Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Kurtesi A; Division of Nephrology, Department of Medicine, University Health Network, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Qi F; Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada.
  • Delgado-Brand M; Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada.
  • Tursun TR; Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada.
  • Hu Q; Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada.
  • Dhruve M; Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada.
  • Kandel C; Division of Nephrology, Michael Garron Hospital, Toronto, ON, Canada.
  • Enilama O; Division of Infectious Diseases, Michael Garron Hospital, Toronto, ON, Canada.
  • Levin A; Division of Experimental Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Jiang Y; British Columbia Provincial Renal Agency, Vancouver, BC, Canada.
  • Hardy WR; Centre for Clinical Trial Support, Sunnybrook Research Institute, Toronto, ON, Canada.
  • Yuen DA; Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada.
  • Perl J; Division of Nephrology, Department of Medicine, Unity Health Toronto, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Chan CT; Division of Nephrology, Department of Medicine, Unity Health Toronto, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Leis JA; Division of Nephrology, Department of Medicine, University Health Network, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Oliver MJ; Division of Infectious Diseases, Department of Medicine, Sunnybrook Health Sciences Centre, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Colwill K; Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Gingras AC; Ontario Renal Network, Toronto, ON, Canada.
  • Hladunewich MA; Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada.
Nat Commun ; 14(1): 6041, 2023 09 27.
Article en En | MEDLINE | ID: mdl-37758707
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacuna nCoV-2019 mRNA-1273 / Fallo Renal Crónico Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacuna nCoV-2019 mRNA-1273 / Fallo Renal Crónico Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Canadá